Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE IN PLASTIC CONTAINER versus POTASSIUM PHOSPHATES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE IN PLASTIC CONTAINER versus POTASSIUM PHOSPHATES.
POTASSIUM CHLORIDE IN PLASTIC CONTAINER vs POTASSIUM PHOSPHATES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium chloride dissociates to potassium ions, which are essential for maintenance of intracellular tonicity, nerve impulse conduction, muscle contraction, and cardiac function.
Phosphate ion is essential for energy metabolism, buffer systems, and bone mineralization. Potassium is a critical intracellular cation for nerve conduction, muscle contraction, and acid-base balance. Coadministration restores electrolyte balance and provides phosphate for cellular function.
10-20 mEq intravenously over 1 hour, not exceeding 10 mEq/hour or 200 mEq per day; oral dosing for hypokalemia: 20-40 mEq 2-4 times daily.
20-40 mEq elemental phosphorus intravenously over 4-6 hours, typically in adults; dose expressed in mmol phosphate: 10-15 mmol phosphate IV over 4 hours. Oral: 1-2 g (250-500 mg elemental phosphorus) 4 times daily.
None Documented
None Documented
No classical terminal half-life; plasma potassium is rapidly regulated by cellular uptake and renal excretion, with equilibration half-life of ~1-2 hours in normal renal function.
Not applicable as a drug; endogenous phosphate has a terminal elimination half-life of 6-8 hours in the setting of renal impairment, but is not clinically significant in normal physiology.
Primarily renal (90% excreted unchanged in urine); minor fecal elimination (<10%) via unabsorbed potassium.
Renal: approximately 90% as phosphate (reabsorbed variably depending on dietary intake and parathyroid hormone activity). Fecal: <10%.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher